Lack of antiepileptic drugs hurts awareness, treatment efforts in Zambia

October 11, 2010

EAST LANSING, Mich. -- Despite an international effort to raise awareness about epilepsy in resource-poor nations, a recently published study found nearly 50 percent of pharmacies in Zambia do not carry antiepileptic drugs, seriously hampering efforts to tackle one of the most cost-effective chronic conditions to treat.

The study, recently published in the American Journal of Tropical Medicine and Hygiene, was led by Gretchen Birbeck, an associate professor of neurology and ophthalmology and director for the International Neurologic & Psychiatric Epidemiology Program in Michigan State University's College of Osteopathic Medicine.

"We were horrified by what we found, not only in terms of availability but also of cost," said Birbeck, who has been studying epilepsy in Zambia for 16 years. "If the drugs aren't available, then it doesn't matter how successful the medical training or outreach efforts are."

The study was one project funded by a $1.4 million, five-year grant she has received from the National Institutes of Health to develop interventions aimed at overcoming the social and medical hurdles that impact epilepsy care in Zambia.

Epilepsy rates in Zambia are about 10 times what they are in the United States, possibly because of the disease's link to cerebral malaria, which is rampant throughout much of Africa. Among the pharmacies surveyed, 49 percent did not carry antiepileptic drugs, and adult out-of-pocket costs ranged from $7 to $30 in U.S. dollars, an immense cost to Zambians, most of who earn less than $1 per day. Pediatric syrups were universally unavailable as well.

"Despite the cost-effective nature of epilepsy treatment, less than 25 percent of people with active epilepsy in the developing world - where about 80 percent of people with epilepsy live - are receiving treatment," Birbeck said.

She said that during the study and interviews with pharmacists, several barriers were discovered to getting drugs to those who need them:

*In 2007, the World Health Organization began encouraging pharmaceutical regulatory authorities in low-income countries to more strictly enforce existing regulations related to the handling of scheduled drugs such as phenobarbitone. Phenobarbitone is the most affordable, first-line antiepileptic drug. An unintended result of the crackdown appears to be that many pharmacists found it too tedious to try stocking the drug. As a result, supply dropped and costs soared.

*Some pharmacists noted the sale of antiepileptic drugs was unpredictable, therefore many of the drugs expired, making it financially harder on the pharmacies to keep current stocks up.

*Many of patients also have far distances to travel and little money, providing even fewer incentives for pharmacies to carry drugs that many people cannot afford.

Birbeck said these hurdles can frustrate health care workers, who feel their hands are tied.

"Obviously, the need to balance drug availability with proper regulatory oversight is a difficult one," she said. "But the lack of trained pharmacists we found also suggests that the human resources for appropriate management of prescription drugs are limited."

Regardless, Birbeck said, social programs such as the World Health Organization/International League Against Epilepsy's "Out of the Shadows" campaign to encourage people with epilepsy to seek care must be preceded by improved access to drugs.

"It's wrong for us to use community-based programs to encourage people with epilepsy to come forward if they cannot get the medicine they need," she said.

Birbeck said the study's results are re-organizing the priorities of her NIH grant project.

"We are working with the Zambian Ministry of Health, trying to improve access to drugs and educating health care workers," she said. "These steps need to be completed before we move forward."
-end-
Birbeck partnered with researchers from the University of Zambia, Chainama Hills College Hospital in Zambia and the country's Ministry of Health.

Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.

Michigan State University

Related Epilepsy Articles from Brightsurf:

Focal epilepsy often overlooked
Having subtler symptoms, a form of epilepsy that affects only one part of the brain often goes undiagnosed long enough to cause unexpected seizures that contribute to car crashes, a new study finds.

Antibodies in the brain trigger epilepsy
Certain forms of epilepsy are accompanied by inflammation of important brain regions.

Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?

Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.

How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.

Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.

Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.

Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.

Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.

Read More: Epilepsy News and Epilepsy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.